CIAM
EVH icon

Caitong International Asset Management’s Evolent Health EVH Stock Holding History

Caitong International Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Buy
51,499
+51,447
+98,937% +$163K 0.02% 536
2025
Q4 		$208 Sell
52
-1,574
-97% -$8.75K ﹤0.01% 1613
2025
Q3 		$13.8K Buy
+1,626
New +$15.8K 0.01% 899
2025
Q1 		– Sell
-835
Closed -$9.39K – 2271
2024
Q4 		$9.39K Buy
+835
New +$14.7K 0.01% 963

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's EVH Position: Q1 2026 in Review

Caitong International Asset Management increased its Evolent Health (EVH) stake by 98,937% in Q1 2026, buying an estimated $163K and bringing the position to 51,499 shares worth $117K. The position accounts for 0.02% of the portfolio, ranked #536.

Caitong International Asset Management first reported a position in EVH in Q4 2024 and has held it in 4 quarters since. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Caitong International Asset Management held 51,499 shares of Evolent Health worth $117K as of Q1 2026.
  • Caitong International Asset Management bought 51,447 Evolent Health shares in Q1 2026, an estimated $163K.
  • Evolent Health made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #536 holding.
  • Caitong International Asset Management first reported a position in Evolent Health in Q4 2024 and has held it in 4 quarters since.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.